Kunnimalaiyaan, Selvi <br/><br/>
Glycogen synthase kinase-3 inhibitor AR-A014418 suppresses pancreatic cancer cell growth via inhibition of GSK-3-mediated Notch1 expression.  [electronic resource] 

 -  HPB : the official journal of the International Hepato Pancreato Biliary Association  Sep 2015 
 - 770-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1477-2574 
<br/><br/><label>Standard No.: </label>10.1111/hpb.12442  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Apoptosis--drug effects<br/>Blotting, Western<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Glycogen Synthase Kinase 3--antagonists & inhibitors<br/>Humans<br/>Immunoprecipitation<br/>Pancreas--metabolism<br/>Pancreatic Neoplasms--drug therapy<br/>Receptor, Notch1--biosynthesis<br/>Thiazoles--pharmacology<br/>Urea--analogs & derivatives